Document Detail

Heparin Bridging vs. Uninterrupted Oral Anticoagulation in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting.
MedLine Citation:
PMID:  22447005     Owner:  NLM     Status:  Publisher    
Background: The anti-thrombotic strategy during coronary stenting is challenging in patients on long-term oral anticoagulation (OAC) because of atrial fibrillation (AF). Uninterrupted OAC (UAC) is increasingly used, but bridging therapy (BT) is still in common use. Methods and Results: Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting (AFCAS) is a prospective multicenter European registry that recruited 963 patients with AF undergoing coronary stenting. To compare the safety of UAC and BT, bleeding complications and major adverse cardiac and cerebrovascular events (MACCE; death, myocardial infarction, target vessel revascularization, stent thrombosis and stroke) were assessed in 290 patients treated with UAC and 161 patients with BT during a 30-day follow-up period. In the BT group, OAC was interrupted for a median of 5 days. Overall bleeding complications tended to be more common in the BT group (18.6% vs. 12.1%, P=0.07), with no significant difference in the rate of major bleeding (2.5% vs. 1.4%) or MACCE (6.2% vs. 3.8%). After adjustment for propensity score, BT was not associated with bleeding complications (odds ratio [OR], 1.38; 95% confidence interval [CI]: 0.77-2.48, P=0.28) or MACCE (OR, 1.16; 95%CI: 0.44-3.05, P=0.76). Periprocedural international normalized ratio was not associated with bleeding or MACCE. Conclusions: UAC does not increase perioperative complications during coronary stenting and is a simple and cost-effective alternative to conventional heparin bridging.
Heli Lahtela; Andrea Rubboli; Axel Schlitt; Pasi P Karjalainen; Matti Niemelä; Saila Vikman; Marja Puurunen; Michael Weber; Josè Valencia; Fausto Biancari; Gregory Y H Lip; K E Juhani Airaksinen;
Related Documents :
22841435 - Structural and functional inverse cardiac remodeling after cavotricuspid isthmus ablati...
11216965 - Reduction of exercise-induced myocardial ischemia during add-on treatment with the angi...
15631535 - Underutilization of beta-adrenoceptor antagonists post-myocardial infarction.
2871745 - Importance of heart rate in determining beta-blocker efficacy in acute and long-term ac...
8037095 - Correlates of spontaneous echo contrast in patients with mitral stenosis and normal sin...
3584715 - Relation between coronary artery stenosis and myocardial purine metabolism, histology a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-9
Journal Detail:
Title:  Circulation journal : official journal of the Japanese Circulation Society     Volume:  -     ISSN:  1347-4820     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137683     Medline TA:  Circ J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Medicine, Turku University Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Assessment of doxorubicin cardiac toxicity using gated ??mTc-hexakis-2-methoxyisobutylisonitrile myo...
Next Document:  Estimation of Left Atrial Pump Function by Mitral Annular Velocity.